International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-4 doi: 10.5281/zenodo.8300895
Original Article
Comparative Study of Outcomes of Longitudinal and Torsional Modes in Phacoemulsification Using Gravity Fluidics along with Intrepid Balanced Tip
 ,
 ,
 ,
Published
Aug. 30, 2023
Abstract

Purpose: To compare the outcomes of longitudinal and torsional modes of phacoemulsification with foldable intraocular lens implantation surgery using an intrepid balanced tip with gravity fluidics system.

Methods: This single-centre prospective study comprised a total of 80 eyes of 80 patients having senile cataract with nuclear opalescence (NO) grade II-IV (LOCS III). Cataracts of each grade were randomly assigned into 2 groups LPKE and TPKE mode. All the patients were operated by the same surgeon using the same machine having gravity fluidics using an intrepid balanced tip. Patients were evaluated on postoperative days (PODs) 1,7,15 and 30 for BCVA, CCT, and ECD. Intraoperative outcome measures were cumulative dissipated energy (CDE) and ultrasound time (UST). Postoperative outcome measures were best corrected visual acuity (BCVA), central corneal thickness (CCT), and endothelial cell density (ECD) on days 1,7,15, and 28.

Results: The difference of CDE and UST between the 2 modes was found to be significant (p<0.001) in favor of TPKE mode in all NO grades. TPKE mode performs better than LPKE mode regarding ECL, CCT change, and BCVA change, although the differences were insignificant (P > 0.05).

Conclusion: When using gravity fluidics along with the intrepid balanced tip, TPKE mode appeared to be a more efficient mode of PKE with reduced mean UST and CDE across all NO grades, as compared to LPKE mode. However, ECL, CCT change, and BCVA change seemed to be comparable between the two modes.

Recommended Articles
Loading Image...
Volume-4, Issue-4
Citations
2987 Views
177 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved